Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC

Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC

BackgroundN6-methyladenosine (m6A) RNA modification is crucial for tumor development and progression; however, which m6A regulators play a pivotal role in head and neck squamous cell carcinoma (HNSCC) remains ambiguous.MethodsUtilizing the Cancer Genome Atlas (TCGA) database, the expression levels o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yulin Zhang, Yixu Wang, Jilin Peng, Kun Zhao, Ling Li, Yuan Zhang, Ziyu Zhai, Sijie Yuan, Shichao Li, Fanglei Ye, Le Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Oncology
Subjects:	heterogeneous nuclear ribonucleoprotein C head and neck squamous cell carcinoma prognostic significance tumor progression N6-methyladenosine
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1516867/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The HNRNPC/CELF2 signaling pathway drives glycolytic reprogramming and mitochondrial dysfunction in drug-resistant acute myeloid leukemia
by: Xiang Ma, et al.
Published: (2025-05-01)

Integrated multi-omics reveal lactate metabolism-related gene signatures and PYGL in predicting HNSCC prognosis and immunotherapy efficacy
by: Xiaochuan Chen, et al.
Published: (2025-04-01)

An energy metabolism-related signature relevant to the tumor immune microenvironment in HNSCC
by: Kaiyu Zhu, et al.
Published: (2025-05-01)

Single-cell insights into HNSCC tumor heterogeneity and programmed cell death pathways
by: Yuanhao Chai, et al.
Published: (2025-04-01)

Neoadjuvant toripalimab combined with chemotherapy in locally advanced HNSCC
by: Zhaoyang Wang, et al.
Published: (2025-05-01)

Comparative effectiveness and safety of imported and domestic immune checkpoint inhibitors in China: A systematic review and pairwise and network meta-analyses
by: Jilin Peng, et al.
Published: (2024-12-01)

The efficacy and safety of a taxane-based chemotherapy regimen combined with a PD-1 inhibitor in HNSCC: a multicenter real-world study
by: Min Ouyang, et al.
Published: (2025-01-01)

FTO-mediated demethylation of MTUS1/ATIP1 promotes tumor progression in head and neck squamous cell carcinoma
by: Dongxiao Tang, et al.
Published: (2024-12-01)

Clinical and molecular characterizations of HNSCC patients with occult lymph node metastasis
by: Yicun Li, et al.
Published: (2025-07-01)

Targeting PERP promotes anti-tumor immunity in HNSCC by regulating tumor immune microenvironment and metabolic homeostasis
by: Xueying Wang, et al.
Published: (2025-06-01)

Deciphering a proliferation-essential gene signature based on CRISPR-Cas9 screening to predict prognosis and characterize the immune microenvironment in HNSCC
by: Ke-ling Pang, et al.
Published: (2025-04-01)

The expression of GSDM protein family in HNSCC and its impact on prognosis
by: LIU Wei, et al.
Published: (2025-02-01)

<i>FMR1</i> Disorders: Basics of Biology and Therapeutics in Development
by: Drew A. Gillett, et al.
Published: (2024-12-01)

A dynamic co-expression approach reveals Gins2 as a potential upstream modulator of HNSCC metastasis
by: Nasibeh Khayer, et al.
Published: (2025-01-01)

Small nuclear ribonucleoprotein polypeptide B2 regulated by SNHG4/miR-204-5p axis inhibits ferroptosis to aggravate the progression of hepatocellular carcinoma
by: Jiaxing Guo, et al.
Published: (2025-07-01)

Somatostatin receptor-targeted polymeric nanoplatform for efficient CRISPR/Cas9 gene editing to enhance synergistic hepatocellular carcinoma therapy
by: Suqin Zhang, et al.
Published: (2025-02-01)

Prognostic analysis of 1 026 patients with head and neck squamous cell carcinoma based on SEER database
by: LI Qian, et al.
Published: (2023-08-01)

CircRNA_036186 mediates HNSCC progression by regulating 14-3-3ζ
by: Juan Tang, et al.
Published: (2024-12-01)

DNA-PKcs Dysfunction Enhances the Antitumor Activity of Radioimmunotherapy by Activating the cGAS-STING Pathway in HNSCC
by: Chen L, et al.
Published: (2025-03-01)

Single-cell RNA sequencing reveals an IL1R2+Treg subset driving immunosuppressive microenvironment in HNSCC
by: Haiyan Guo, et al.
Published: (2025-03-01)

Regulatory Effects of SLC7A2‐CPB2 on Lymphangiogenesis: A New Approach to Suppress Lymphatic Metastasis in HNSCC
by: Kai Song, et al.
Published: (2024-10-01)

Emerging roles of RNA methylation modifications in environmental metalloid or metal pollutants toxicity
by: Rongxian Li, et al.
Published: (2025-07-01)

Identification and validation of M2 macrophage-related gene signature as a novel prognostic model for head and neck squamous cell carcinoma
by: Shengmei He, et al.
Published: (2024-10-01)

Molecular Markers of Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients
by: Piero Giuseppe Meliante, et al.
Published: (2025-02-01)

Commentary: Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC
by: Jihao Xue, et al.
Published: (2025-03-01)

Expression patterns and clinical significance of vasculogenic mimicry-related genes in patients with head and neck squamous cell carcinoma
by: Rui Lai, et al.
Published: (2025-08-01)

Mixed connective tissue disease with juvenile onset: results of a retrospective single-center study
by: M. I. Kaleda, et al.
Published: (2024-02-01)

Combined single-cell RNA-seq and bulk RNA-seq construction of M2 TAMs signature for predicting HNSCC prognosis and immunotherapy
by: Jiale Wang, et al.
Published: (2025-08-01)

Identification of key differentially methylated genes regulating muscle development in chickens: insights from Jingyuan breed
by: Tong Zhang, et al.
Published: (2024-12-01)

Inhibiting NHEJ in HNSCC cell lines by the ligase IV inhibitor SCR130 has limited radiosensitizing effects
by: Laura S. Hildebrand, et al.
Published: (2025-05-01)

The Correlation Analysis Between m6A Methylation Modification and Ferroptosis Induced by Cigarette Smoke in Human Bronchial Epithelium
by: Xiaomei Duan, et al.
Published: (2024-12-01)

Pseudogene pair-based prognostic model reveals LAT as a biomarker of immune response in head and neck squamous cell carcinoma
by: Qin Ding, et al.
Published: (2025-08-01)

Clinicopathological and prognostic role of CEP55 expression in cancer patients: A meta‐analysis of 31 studies with 12,543 patients
by: Jiangguo Zhang, et al.
Published: (2024-12-01)

Development of a m6A- and ferroptosis-related LncRNA signature for forecasting prognosis and treatment response in cervical cancer
by: Kaiting Wen, et al.
Published: (2025-03-01)

Systematic analysis of chemotherapy, immunotherapy, and combination therapy in Head and Neck Squamous Cell Carcinoma (HNSCC) clinical trials: Focusing on overall survival and progression-free survival outcomes
by: Priya Ganesan, et al.
Published: (2024-12-01)

Regulatory mechanisms of m6A RNA methylation in esophageal cancer: a comprehensive review
by: Long Wen, et al.
Published: (2025-04-01)

Interplay of m6A RNA methylation and gut microbiota in modulating gut injury
by: Haixia Wang, et al.
Published: (2025-12-01)

Adaptation to Arginine Deprivation Leads to a More Aggressive, Therapy-Resistant Phenotype in HNSCC Cells
by: Oleg Chen, et al.
Published: (2025-06-01)

Molecular classification of head and neck squamous cell carcinoma based on hypoxia-related genes and clinical significance of STC2
by: ZHU Jianing, WANG Tiantian, ZHANG Rui, SONG Hongquan
Published: (2025-05-01)

Transcriptome-wide study of mRNAs modified by m6A RNA methylation in the testis development of dairy goats
by: Xinyang Ren, et al.
Published: (2025-12-01)